Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Identifying dangerous infections early

16.10.2013
Harmful bacteria can colonize artificial joints or other implants in the body. Researchers from Würzburg and the Netherlands have developed a method for detecting such infections early.

Staphylococci are bacteria that are particularly feared in hospitals. This is because a staphylococcal infection can be life-threatening for patients whose immune system is weakened, as is the case, for example, after a major procedure such as an organ transplant. Staphylococci pose special problems since they are also resistant to various antibiotics.


Evidence of a staphylococcal infection in the leg muscle of a mouse with the new fluorescent agent vanco-800CW. A fluorescence signal can be seen beneath the pelvis of the animal because the agent collects in the bladder before it is excreted in urine.

Image: Kevin P. Francis, Caliper (Alameda, California, USA)

Such infections are also dangerous for patients who receive artificial joints, for instance, or other implants. With implants, in particular, there is a risk of the bacteria forming so-called biofilms on top of them: the microbes surround themselves with a mucus sheath, which protects them very well against medication.

Possible consequences of an infection

“If an infection of this kind gets out of hand, the implant may have to be surgically removed again,” says Knut Ohlsen from the Institute for Molecular Infection Biology at the University of Würzburg. After that, the infected region is “remediated” before a new implant can be inserted. All in all, this is a lengthy process and one that is very stressful for the patient.

So, it is important to identify implant infections as early as possible. Now, for the first time, research teams from the University of Groningen in the Netherlands are presenting a suitable method in the journal “Nature Communications”. Knut Ohlsen and Tina Schäfer from the University of Würzburg helped develop it.

How the new “tracker” works

The scientists have developed an agent that could be described as a “fluorescent tracker”: it locates even the smallest quantities of harmful staphylococci in the body and marks them so that they can be identified from outside with a special camera. The “tracker” is the common antibiotic Vancomycin coupled to a new fluorescent dye.

The technique has proven its suitability in experiments with mice. If it can also be used in humans, it may be possible to avoid implant infections and secondary operations in the future: if there are any signs of an infection after an implant has been inserted, such as a fever or abnormal protein in the blood, the “tracker” could be administered to the patient as a contrast agent. Then, using a video camera that records the agent’s fluorescence signals, the location and extent of the infection could be determined immediately and countermeasures introduced.

The new agent called vanco-800CW is now set to be developed further for use in humans under the direction of the Dutch researchers. Corresponding clinical trials are being planned.

What was done in Würzburg

As part of the project, Tina Schäfer and Knut Ohlsen examined the suitability of the new agent. Which bacteria does the fluorescence-labeled Vancomycin provide any evidence of and how well can its fluorescence be shown with different detection techniques? These questions were answered in Würzburg. Fluorescence imaging is a focus of research activity at the Institute for Molecular Infection Biology. The work is funded by the German Research Foundation (DFG) in Transregional Collaborative Research Center 34.

“Real-time in vivo imaging of invasive- and biomaterial-associated bacterial infections using fluorescently labeled vancomycin”, Marleen van Oosten, Tina Schäfer, Joost A.C. Gazendam, Knut Ohlsen, Eleni Tsompanidou, Marcus C. de Goffau, Hermie J.M. Harmsen, Lucia M.A. Crane, Ed Lim, Kevin P. Francis, Lael Cheung, Michael Olive, Vasilis Ntziachristos, Jan Maarten van Dijl, Gooitzen M. van Dam. Nature Communications, 15 October 2013, DOI: 10.1038/ncomms3584

Contact

Dr. Knut Ohlsen, Institute for Molecular Infection Biology, University of Würzburg, T +49 (0)931 31-82155, knut.ohlsen@uni-wuerzburg.de

Robert Emmerich | Uni Würzburg
Further information:
http://www.uni-wuerzburg.de

More articles from Health and Medicine:

nachricht How cancer metastasis happens: Researchers reveal a key mechanism
19.01.2018 | Weill Cornell Medicine

nachricht Researchers identify new way to unmask melanoma cells to the immune system
17.01.2018 | Duke University Medical Center

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Artificial agent designs quantum experiments

On the way to an intelligent laboratory, physicists from Innsbruck and Vienna present an artificial agent that autonomously designs quantum experiments. In initial experiments, the system has independently (re)discovered experimental techniques that are nowadays standard in modern quantum optical laboratories. This shows how machines could play a more creative role in research in the future.

We carry smartphones in our pockets, the streets are dotted with semi-autonomous cars, but in the research laboratory experiments are still being designed by...

Im Focus: Scientists decipher key principle behind reaction of metalloenzymes

So-called pre-distorted states accelerate photochemical reactions too

What enables electrons to be transferred swiftly, for example during photosynthesis? An interdisciplinary team of researchers has worked out the details of how...

Im Focus: The first precise measurement of a single molecule's effective charge

For the first time, scientists have precisely measured the effective electrical charge of a single molecule in solution. This fundamental insight of an SNSF Professor could also pave the way for future medical diagnostics.

Electrical charge is one of the key properties that allows molecules to interact. Life itself depends on this phenomenon: many biological processes involve...

Im Focus: Paradigm shift in Paris: Encouraging an holistic view of laser machining

At the JEC World Composite Show in Paris in March 2018, the Fraunhofer Institute for Laser Technology ILT will be focusing on the latest trends and innovations in laser machining of composites. Among other things, researchers at the booth shared with the Aachen Center for Integrative Lightweight Production (AZL) will demonstrate how lasers can be used for joining, structuring, cutting and drilling composite materials.

No other industry has attracted as much public attention to composite materials as the automotive industry, which along with the aerospace industry is a driver...

Im Focus: Room-temperature multiferroic thin films and their properties

Scientists at Tokyo Institute of Technology (Tokyo Tech) and Tohoku University have developed high-quality GFO epitaxial films and systematically investigated their ferroelectric and ferromagnetic properties. They also demonstrated the room-temperature magnetocapacitance effects of these GFO thin films.

Multiferroic materials show magnetically driven ferroelectricity. They are attracting increasing attention because of their fascinating properties such as...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

10th International Symposium: “Advanced Battery Power – Kraftwerk Batterie” Münster, 10-11 April 2018

08.01.2018 | Event News

See, understand and experience the work of the future

11.12.2017 | Event News

Innovative strategies to tackle parasitic worms

08.12.2017 | Event News

 
Latest News

Let the good tubes roll

19.01.2018 | Materials Sciences

How cancer metastasis happens: Researchers reveal a key mechanism

19.01.2018 | Health and Medicine

Meteoritic stardust unlocks timing of supernova dust formation

19.01.2018 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>